Two brutal recessions wiped out dividends across the market, yet a handful of healthcare companies kept raising their payouts through every quarter of both downturns.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Abbott (ABT) concluded the recent trading session at $111.59, signifying a -2.2% move from its prior day's close.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| KH Kevin Heal ARGUS INVESTORS' COUNSEL Inc. | 2,623 | $287,229.81 | $291,402.18 | $4,172.37 | 1.45% |
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 49,558 | $6.01M | $5.52M | -$491,878.78 | -8.18% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 4,706 | $572,060.08 | $524,107.22 | -$47,952.86 | -8.38% |
Michelle S. Hickox FIRST FINANCIAL BANKSHARES Inc. | 119,011 | $13.15M | $13.26M | $111,659.55 | 0.85% |
Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 779 | $81,575.02 | $86,718.28 | $5,143.26 | 6.3% |
| Pharmaceuticals Industry | Healthcare Sector | Robert Ford CEO | NYSE Exchange | 002824100 CUSIP |
| US Country | 115,000 Employees | 15 Jul 2026 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains: